Skip to main content
Fig. 5 | BMC Pulmonary Medicine

Fig. 5

From: Folate-modified liposomes mediate the co-delivery of cisplatin with miR-219a-5p for the targeted treatment of cisplatin-resistant lung cancer

Fig. 5

In vitro therapeutic effect of the nanodrugs. (a) Colony formation assay results of A549/DDP cells in different experimental groups; (b) Cell migration status at 0 and 24 h in different experimental groups using a wound healing assay; (c) The influence of various drug treatments on the cell viability of A549 cells; (d) The expression levels of miR-219a-5p in BEAS-2B, A549, and DDP-resistant A549 (A549/DDP) cell lines as tested by qRT-PCR; (e) The impact of various nanodrug treatments on the cell viability of DDP-resistant/non-resistant A549 cells; (f) The results of flow cytometry analysis of the apoptosis of A549/DDP cells in each treatment group; (g) The western blot analysis results of A549/DDP cells after nanodrug treatments; *p < 0.05

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us